Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation

W. J. M. Mackus, A. P. Kater, A. Grummels, L. M. Evers, B. Hooijbrink, M. H. H. Kramer, J. E. Castro, T. J. Kipps, R. A. W. van Lier, M. H. J. van Oers, E. Eldering

Research output: Contribution to journalArticleAcademicpeer-review

76 Citations (Scopus)

Abstract

We investigated the apoptosis gene expression profile of chronic lymphocytic leukemia (CLL) cells in relation to (1) normal peripheral and tonsillar B-cell subsets, (2) IgV(H) mutation status, and (3) effects of cytotoxic drugs. In accord with their noncycling, antiapoptotic status in vivo, CLL cells displayed high constitutive expression of Bcl-2 and Flip mRNA, while Survivin, Bid and Bik were absent. Paradoxically, along with these antiapoptotic genes CLL cells had high-level expression of proapoptotic BH3-only proteins Bmf and Noxa. Treatment of CLL cells with fludarabine induced only the proapoptotic genes Bax and Puma in a p53-dependent manner. Interestingly, the degree of Puma induction was more pronounced in cells with mutated IgVH genes. Thus, disturbed apoptosis in CLL is the net result of both protective and sensitizing aberrations. This delicate balance can be tipped via induction of Puma in a p53-dependent matter, the level of which may vary between groups of patients with a different tendency for disease progression
Original languageEnglish
Pages (from-to)427-434
JournalLeukemia
Volume19
Issue number3
DOIs
Publication statusPublished - 2005

Cite this